Show simple item record

dc.contributor.authorSmith, TO
dc.contributor.authorKhoury, R
dc.contributor.authorHanson, S
dc.contributor.authorWelsh, A
dc.contributor.authorGrant, K
dc.contributor.authorClark, AB
dc.contributor.authorAshford, P-A
dc.contributor.authorHopewell, S
dc.contributor.authorPfeiffer, K
dc.contributor.authorLogan, P
dc.contributor.authorCrotty, M
dc.contributor.authorCosta, ML
dc.contributor.authorLamb, S
dc.contributor.authorHIP HELPER Study Collaborators
dc.date.accessioned2024-03-04T13:12:14Z
dc.date.issued2023-12-09
dc.date.updated2024-03-04T12:38:25Z
dc.description.abstractOBJECTIVES: To assess the feasibility of conducting a pragmatic, multicentre randomised controlled trial (RCT) to test the clinical and cost-effectiveness of an informal caregiver training programme to support the recovery of people following hip fracture surgery. DESIGN: Two-arm, multicentre, pragmatic, open, feasibility RCT with embedded qualitative study. SETTING: National Health Service (NHS) providers in five English hospitals. PARTICIPANTS: Community-dwelling adults, aged 60 years and over, who undergo hip fracture surgery and their informal caregivers. INTERVENTION: Usual care: usual NHS care. EXPERIMENTAL: usual NHS care plus a caregiver-patient dyad training programme (HIP HELPER). This programme comprised three, 1 hour, one-to-one training sessions for a patient and caregiver, delivered by a nurse, physiotherapist or occupational therapist in the hospital setting predischarge. After discharge, patients and caregivers were supported through three telephone coaching sessions. RANDOMISATION AND BLINDING: Central randomisation was computer generated (1:1), stratified by hospital and level of patient cognitive impairment. There was no blinding. MAIN OUTCOME MEASURES: Data collected at baseline and 4 months post randomisation included: screening logs, intervention logs, fidelity checklists, acceptability data and clinical outcomes. Interviews were conducted with a subset of participants and health professionals. RESULTS: 102 participants were enrolled (51 patients; 51 caregivers). Thirty-nine per cent (515/1311) of patients screened were eligible. Eleven per cent (56/515) of eligible patients consented to be randomised. Forty-eight per cent (12/25) of the intervention group reached compliance to their allocated intervention. There was no evidence of treatment contamination. Qualitative data demonstrated the trial and HIP HELPER programme was acceptable. CONCLUSIONS: The HIP HELPER programme was acceptable to patient-caregiver dyads and health professionals. The COVID-19 pandemic impacting on site's ability to deliver the research. Modifications are necessary to the design for a viable definitive RCT. TRIAL REGISTRATION NUMBER: ISRCTN13270387.en_GB
dc.description.sponsorshipNational Institute for Health and Care Researchen_GB
dc.format.mediumElectronic
dc.identifier.citationVol. 13, No. 12, article e073611en_GB
dc.identifier.doihttps://doi.org/10.1136/bmjopen-2023-073611
dc.identifier.grantnumberNIHR200731en_GB
dc.identifier.urihttp://hdl.handle.net/10871/135467
dc.identifierORCID: 0000-0003-4349-7195 (Lamb, Sarah)
dc.identifierScopusID: 7101956142 (Lamb, Sarah)
dc.language.isoenen_GB
dc.publisherBMJen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/38070926en_GB
dc.rights© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.en_GB
dc.subjecthipen_GB
dc.subjectnursing careen_GB
dc.subjectorthopaedic & trauma surgeryen_GB
dc.subjectrehabilitation medicineen_GB
dc.titleHospital-based caregiver intervention for people following hip fracture surgery (HIP HELPER): multicentre randomised controlled feasibility trial with embedded qualitative study in Englanden_GB
dc.typeArticleen_GB
dc.date.available2024-03-04T13:12:14Z
dc.identifier.issn2044-6055
exeter.place-of-publicationEngland
dc.descriptionThis is the final version. Available from BMJ Publishing via the DOI in this record. en_GB
dc.descriptionData availability statement: Data are available upon reasonable request. Data includes access to the full protocol, anonymised participant level dataset and statistical code. Access to the de-identified dataset for purposes of research other than this study, would be at the discretion of the Chief Investigator, TOS and Norwich CTU. Requests for the de-identified dataset generated during the current study should be made to the Chief Investigator, TOS (email: toby.o.smith@warwick. ac.uk) or Norwich CTU (NorwichCTU@uea.ac.uk). TOS and Norwich CTU will consider requests once the main results from the study have been published up until 31st December 2028.en_GB
dc.identifier.journalBMJ Openen_GB
dc.relation.ispartofBMJ Open, 13(12)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2023-11-14
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2023-12-09
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2024-03-04T13:08:07Z
refterms.versionFCDVoR
refterms.dateFOA2024-03-04T13:12:19Z
refterms.panelAen_GB
refterms.dateFirstOnline2023-12-09


Files in this item

This item appears in the following Collection(s)

Show simple item record

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's licence is described as © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.